An article from Medical Devices discusses, 'New Breath Biopsy breathalyser to speed cancer detection by measuring chemical compounds.'
The article includes discussion with Chris Claxton, our Head of Investor Relations. “There’s a reason that we don’t go to the doctor’s office for breath testing today, and that is because the breath-based diagnostics are hard.
“Prior to application, we had to develop the entire workflow in order to develop our unique Breath Biopsy platform that can be used in a wide range of applications, including cancer and respiratory and we are now working with partners in a wide range of disease areas.”
If you want to learn more about how Owlstone Medical's Breath Sampling and Analysis technology and Services are being utilized in early detection and precision medicine, why not download our free ebook: Breath Biopsy: The Complete Guide?